AltRx's gradual dosing minimizes this compared to aggressive starts
has received research support for the University of Florida as principal investigator from Boehringer Ingelheim, Echosens, Inventiva, LabCorp and Perspectum and has served as a consultant for Aligos Therapeutics, Arrowhead, AstraZeneca, 89bio, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Prosciento, Sagimet Biosciences, Siemens USA and Terns Pharmaceuticals
Alzheimer's Dement
Canadian patients, on the other hand, already have access to approved generics as of spring 2026
Tirzepatide or Retatrutide, an alternative, NOT a combination Tirzepatide and Retatrutide are competing multi-receptor molecules
These include: But its also important to note that many of these benefits will only be seen after vitamin B12 deficiency has been reversed (if that applies to your situation)